Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants
Sign Up to like & getrecommendations! Published in 2022 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2022-323807
Abstract: Objectives Intranasal nalbuphine could be a safe, efficacious and non-invasive alternative to parenteral pain medication in infants. We aimed to assess pharmacokinetics (PK) and tolerability of intranasal and intravenous nalbuphine administration in infants. Methods Prospective… read more here.
Keywords: administration; pharmacokinetics tolerability; tolerability intranasal; intranasal intravenous ... See more keywords